Related Experiment Video
Updated: Aug 2, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Lowering cholesterol in old age
1National Heart and Lung Institute, Imperial College School of Science, Technology and Medicine, London.
Insights
Lowering cholesterol in older adults requires a conservative approach. Evidence for benefits is lacking, and treatment decisions should prioritize individual clinical judgment and patient well-being.
Area of Science:
- Gerontology
- Cardiovascular Medicine
- Pharmacology
Background:
- Plasma cholesterol levels naturally decline with age.
- The association between cholesterol and vascular disease diminishes in advanced age.
Purpose of the Study:
- To advocate for a conservative stance on cholesterol-lowering interventions in the elderly.
- To evaluate the evidence supporting lipid-lowering treatments in older populations.
Main Methods:
- Review of existing literature on cholesterol, aging, and vascular disease.
- Analysis of data regarding the efficacy and risks of lipid-lowering drugs in the elderly.
Main Results:
- Spontaneous decrease in plasma cholesterol concentrations observed with aging.
- Weakening of the correlation between cholesterol levels and vascular disease in older individuals.
- Lack of robust data demonstrating clear benefits of cholesterol reduction in the elderly.
Conclusions:
- A cautious approach is recommended for lowering plasma cholesterol in advanced age.
- Continued lipid-lowering treatment beyond age 75 for patients with coronary heart disease may be considered, based on clinical judgment.
- Conflicting priorities, including treatment costs, influence therapeutic decisions in elderly care.
Abstract:
In arguing for a conservative view of the need for and wisdom of lowering plasma cholesterol, or low density lipoprotein cholesterol, in advanced age, three considerations are taken into account. These are: plasma cholesterol concentrations decrease spontaneously with age, as does their association with vascular disease; the absence of data to demonstrate the benefits of lowering cholesterol levels in the elderly; and conflicting priorities (including the cost of treatment) in the care of the elderly. Patients with known coronary heart disease who have received lipid-lowering treatment for some years could continue to be treated with these drugs beyond the age of 75, though even this decision should depend on clinical judgement.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management

